当前位置:首页 - 行情中心 - 华恒生物(688639) - 财务分析 - 现金流量表

华恒生物

(688639)

  

流通市值:71.12亿  总市值:71.20亿
流通股本:2.49亿   总股本:2.50亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金648,660,311.452,323,340,962.091,491,262,060.07969,862,705.67
收到的税费返还25,589,077.8793,893,173.08136,549,820.5443,687,160.63
收到其他与经营活动有关的现金4,914,079.8146,354,143.5233,887,18016,980,054.72
经营活动现金流入的平衡项目0000
经营活动现金流入小计679,163,469.132,463,588,278.691,661,699,060.611,030,529,921.02
购买商品、接受劳务支付的现金538,608,822.31,741,412,214.141,181,141,558.2695,877,081.98
支付给职工以及为职工支付的现金93,815,077.99270,733,005.97211,290,777.46137,617,472.76
支付的各项税费4,312,265.493,441,048.2935,150,250.1128,956,328.24
支付其他与经营活动有关的现金26,706,219.17158,207,398.66129,509,846.4885,105,565.94
经营活动现金流出的平衡项目0000
经营活动现金流出小计663,442,384.862,263,793,667.061,557,092,432.25947,556,448.92
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额15,721,084.27199,794,611.63104,606,628.3682,973,472.1
二、投资活动产生的现金流量:
处置固定资产、无形资产和其他长期资产收回的现金净额-367,445.2176,82360,250
收到的其他与投资活动有关的现金560,0003,247,706.8313,633,071.2610,523,248
投资活动现金流入的平衡项目0000
投资活动现金流入小计560,0003,615,152.0413,709,894.2610,583,498
购建固定资产、无形资产和其他长期资产支付的现金93,009,462.7923,510,013.72626,000,987.17436,211,520.36
投资支付的现金-10,200,0008,100,0008,100,000
支付其他与投资活动有关的现金2,090,000-11,015,0008,735,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计95,099,462.7933,710,013.72645,115,987.17453,046,520.36
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-94,539,462.7-930,094,861.68-631,406,092.91-442,463,022.36
三、筹资活动产生的现金流量:
吸收投资收到的现金-689,127,738.195,318,678.75,318,678.7
取得借款收到的现金396,621,603.931,761,064,802.261,404,015,794.15828,053,170.92
筹资活动现金流入平衡项目0000
筹资活动现金流入小计396,621,603.932,450,192,540.451,409,334,472.85833,371,849.62
偿还债务支付的现金311,437,333.191,471,406,681.37616,088,269.19407,383,401.18
分配股利、利润或偿付利息支付的现金9,884,947.29183,407,679.85170,403,346.7220,881,896.93
支付其他与筹资活动有关的现金-14,628,578.1112,886,137.5412,886,137.54
筹资活动现金流出平衡项目0000
筹资活动现金流出小计321,322,280.481,669,442,939.33799,377,753.45441,151,435.65
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额75,299,323.45780,749,601.12609,956,719.4392,220,413.97
四、汇率变动对现金及现金等价物的影响6,481,912.6612,015,901.059,654,463.178,317,616.57
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额2,962,857.6862,465,252.1292,811,718.0241,048,480.28
加:期初现金及现金等价物余额414,959,350.9352,494,098.78352,494,098.78352,494,098.78
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额417,922,208.58414,959,350.9445,305,816.8393,542,579.06
补充资料:
净利润-184,557,880.58-147,992,111.97
资产减值准备-3,179,964.26-183,649.98
固定资产和投资性房地产折旧-135,180,224.36-64,965,992.13
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-135,180,224.36-64,965,992.13
无形资产摊销-3,476,610.57-1,544,940.12
长期待摊费用摊销-934,630.12--
处置固定资产、无形资产和其他长期资产的损失-64,164.74-66,998.76
固定资产报废损失-305,607.46-78,926.39
财务费用-25,850,710.95-8,272,606.66
投资损失--853,142.53-51,080.29
递延所得税--6,717,501.73-6,452,034.63
其中:递延所得税资产减少--37,144,423.46--12,415,405.71
递延所得税负债增加-30,426,921.73-18,867,440.34
存货的减少--181,096,316.29--36,257,068.09
经营性应收项目的减少--58,418,008.6--13,781,710.26
经营性应付项目的增加-85,664,509.34--96,074,493.95
其他-8,745,700--
现金的期末余额-414,959,350.9-393,542,579.06
减:现金的期初余额-352,494,098.78-352,494,098.78
公告日期2025-04-232025-04-232024-10-292024-08-28
审计意见(境内)标准无保留意见
TOP↑